Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in OCGN — Ocugen, Inc.

CIK 1115418 BOSTON, MA
Back to OCGN Full portfolio

Position in OCGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$520,954
+$277,293 QoQ
Shares Held
340,493
-1.3% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 147 holders
Holding Since
Jun 2021
17 quarters on record
Voting authority Sole 23% Shared 0% None 77%

Common Shares in OCGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. OCGN ranks #179 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 396,380 $196,893,837
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,794 $98,390,870
3 MRNA
Moderna, Inc.
 809,853 $56,714,005
4 ALNY
Alnylam Pharmaceuticals, Inc.
 165,579 $49,844,246
5 INCY
Incyte Corp
 428,533 $48,578,500
6 RVMD
Revolution Medicines, Inc.
 226,008 $42,326,778
7 ROIV
Roivant Sciences Ltd.
 1,178,789 $41,717,342
8 JAZZ
Jazz Pharmaceuticals plc
 163,018 $39,282,447

All Filings in OCGN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $520,954 340,493
2025-03-31 $243,661 345,130
2024-12-31 $261,202 324,475
2024-09-30 $285,141 287,441
2024-06-30 $466,887 301,218
2024-03-31 $15,732 9,593
2023-12-31 $5,515 9,593
2023-09-30 $3,837 9,593
2023-06-30 $9,246 17,028
2023-03-31 $245,707 288,051
2022-12-31 $361,266 277,897
2022-09-30 $477,607 268,319
2022-06-30 $566,342 249,490
2022-03-31 $635,243 192,498
2021-12-31 $879,697 193,340
2021-09-30 $1,408,357 196,150
2021-06-30 $1,537,624 191,485